• 1
    D'Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology 1995; 22:332353. MEDLINE
  • 2
    Grace ND, Groszmann RJ, Garcia-Tsao G, Burroughs AK, Pagliaro L, Makuch RW, Bosch J, et al. Portal hypertension and variceal bleeding: an AASLD single topic symposium. Hepatology 1998; 28:868880. MEDLINE
  • 3
    de Franchis R, Pascal JP, Ancona E, Burroughs AK, Henderson JM, Fleig W, Groszmann RJ, et al. Definitions, methodology and therapeutic strategies in portal hypertension. A Consensus Development Workshop. J Hepatol 1992; 15:256261. MEDLINE
  • 4
    Hartigan PM, Gebhard RL, Gregory PB for the VACVSG. Sclerotherapy for actively bleeding esophageal varices in male alcoholics with cirrhosis. Gastrointest Endosc 1997; 46:17. MEDLINE
  • 5
    Laine L, El-Newihi HM, Migikovsky B, Sloane R, Garcia F. Endoscopic ligation compared with sclerotherapy for treatment of bleeding esophageal varices. Ann Intern Med 1993; 119:17. MEDLINE
  • 6
    Planas R, Quer JC, Boix J, Canet J, Armengol M, Cabre E, Pintanel T, et al. A prospective randomized trial comparing somatostatin and sclerotherapy in the treatment of acute variceal bleeding. Hepatology 1994; 20: 370375 MEDLINE
  • 7
    Escorsell A, Ruiz del Arbol L, Planas R, Albillos A, Bañares R, Calès P, Pateron D, et al. Multicenter randomized controlled trial of terlipressin versus sclerotherapy in the treatment of acute variceal bleeding: the TEST study. Hepatology 2000; 32:471476. MEDLINE
  • 8
    Escorsell A, Bandi JC, Andreu V, Moitinho E, Garcia-Pagan JC, Bosch J, Rodes J. Desensitization to the effects of intravenous octreotide in cirrhotic patients with portal hypertension. Gastroenterology 2001; 120:161169. MEDLINE
  • 9
    Corley DA, Cello JP, Adkisson W, Ko WF, Kerlikowske K. Octreotide for acute esophageal variceal bleeding: a meta-analysis. Gastroenterology 2001; 120:946954. MEDLINE
  • 10
    Sung JJ, Chung SG, Yung MY, Lai CW, Law JY, Lee YT, Leung VK, et al. Prospective randomised study of effect of octreotide on rebleeding from oesophageal varices after endoscopic ligation. Lancet 1995; 346:16661669. MEDLINE
  • 11
    Besson I, Ingrand P, Person B, Boutroux D, Heresbach D, Bernard P, Hochain P, et al. Sclerotherapy with or without octreotide for acute variceal bleeding. N Engl J Med 1995; 333:550560. MEDLINE
  • 12
    Ceriani R, Curioni R, Morini L, Repaci G, Brunati S. Sclerotherapy alone (ES) vs. Sclerotherapy plus terlipressin (EST) vs. sclerotherapy plus octreotide (ESO) in the treatment of acute variceal bleeding [Abstract]. Gastroenterology 1997; 112:1238A.
  • 13
    Signorelli S, Negrini F, Paris B, Bonelli M, Girola M. Sclerotherapy with or without somatostatin or octreotide in the treatment of acute variceal haemorrhage: our experience [Abstract]. Gastroenterology 1996; 110:1326A.
  • 14
    Signorelli S, Paris B, Negrini F, Bonelli M, Auriemma L. Esophageal varices bleeding: comparison between treatment with sclerotherapy alone vs sclerotherapy plus octreotide [Abstract]. Hepatology 1997; 26:137A.
  • 15
    Avgerinos A, Nevens F, Raptis S, Fevery J, and the ABOVE Study Group. Early administration of somatostatine and efficacy of sclerotherapy in acute esophageal variceal bleeds: the European Acute Bleeding Oesophageal Variceal Episodes (ABOVE) randomised trial. Lancet 1997; 350:14951499. MEDLINE
  • 16
    Zuberi BF, Baloch Q. Comparison of endoscopic variceal sclerotherapy alone and in combination with octreotide in controlling acute variceal hemorrhage and early rebleeding in patients with low-risk cirrhosis. Am J Gastroenterol 2000; 95:768771. MEDLINE
    Direct Link:
  • 17
    Cales P, Masliah C, Bernard B, Garnier PP, Silvain C, Szostak-Talbodec N, Bronowicki JP, et al. Early administration of vapreotide for variceal bleeding in patients with cirrhosis. N Engl J Med 2001; 334; 2328.
  • 18
    Levacher S, Letoumelin P, Pateron D, Blaisc M, Lapandry C, Pourriat JL. Early administration of terlipressin plus glyceryl trinitrate to control active upper gastrointestinal bleeding in cirrhotic patients. Lancet 1995; 346:865868. MEDLINE
  • 19
    Jadad AR, Moore RA, Carroll D. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17:112. MEDLINE
  • 20
    Robbins J, Brenslow N, Greenland S. Estimators of the Mantel-Haenszel variance consistent in both sparse data and large strata limiting models. Biometrics 1986; 42:311323. MEDLINE
  • 21
    Der Simonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7:177188. MEDLINE
  • 22
    Rosenthal R. The file drawer problem and tolerance for null results. Psychol Bull 1979; 86:638641.
  • 23
    D'Amico G, Pagliaro L, Bosch J. Pharmacological treatment of portal hypertension: an evidence-based approach. Semin Liver Dis 1999; 19:475505. MEDLINE